首页> 外国专利> Method and materials for development of immunological responses protective against malarial infection

Method and materials for development of immunological responses protective against malarial infection

机译:预防疟疾感染的免疫反应的方法和材料

摘要

@ Disclosed are vaccine compositions for use in developing protective immunity against infection by Plasmodium parasites. Soluble proteinaceous immunogens are isolated from the fluid culture medium of in vitro propagated plasmodial species parasites (e.g., P. falciparum) in mammalian erythrocyte culture supernatant or from washes, including hypotonic washes, of cultured erythrocytes parasitized by plasmodium. immunogens so obtained have molecular weights in the range from about 35,000 daltons to about 85,000 daltons and from about 190,000 to about 210,000 daltons. Two principal immunogens of the invention have molecular weights of about 43,000 and about 54,000 daltons, respectively, while a third has a molecular weight of about 200,000. The water soluble immunogens are administered in a suitable carrier such as isotonic salt solution and in combination with a suitable adjuvant such as saponin or, preferably, aluminum hydroxide. Upon administration to vertebrate animals susceptible to plasmodial infection, vaccines according to the invention provoke immune responses protective against morbidity and mortality caused by, e.g., P. falciparum infection. Disclosed also are procedures for optimization of large scale plasmodial parasite growth in human erythrocyte cultures with accompanying development of late erythrocytic stage parasites in large numbers and optimization of isolatable quantities of culture medium supernatant and wash-derived immunogens.
机译:公开了用于发展针对疟原虫寄生虫感染的保护性免疫的疫苗组合物。从哺乳动物红细胞培养上清液中的体外繁殖的疟原虫种寄生虫(例如恶性疟原虫)的液体培养基中分离可溶性蛋白质免疫原,或从被疟原虫寄生的培养的红细胞的洗涤(包括低渗洗涤)中分离。如此获得的免疫原的分子量在约35,000道尔顿至约85,000道尔顿和约190,000至约210,000道尔顿的范围内。本发明的两种主要免疫原的分子量分别为约43,000道尔顿和约54,000道尔顿,而第三种具有约200,000道尔顿。将水溶性免疫原在合适的载体例如等渗盐溶液中,并与合适的佐剂例如皂苷或优选氢氧化铝结合施用。施用给易受疟原虫感染的脊椎动物后,本发明的疫苗可激发免疫应答,以抵抗由例如恶性疟原虫感染引起的发病率和死亡率。还公开了用于优化人红细胞培养物中大规模疟原虫寄生虫生长并伴随大量红细胞后期寄生虫的发展以及可分离量的培养基上清液和来源于洗涤的免疫原的优化的方法。

著录项

  • 公开/公告号EP0136932A3

    专利类型

  • 公开/公告日1986-10-08

    原文格式PDF

  • 申请/专利权人 UNIVERSITY OF ILLINOIS;

    申请/专利号EP19840401685

  • 发明设计人 RISTIC MIODRAG;CHILBERT MARY LYNN;

    申请日1984-08-17

  • 分类号A61K39/015;C12N1/10;C12N15/00;

  • 国家 EP

  • 入库时间 2022-08-22 07:35:48

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号